Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage

BACKGROUND: Methylphenidate (MPH), along with behavioral and psychosocial interventions, is the first-line medication to treat attention-deficit hyperactivity disorder (ADHD) in Sweden. The dose of MPH for good symptom control differs between patients. However, studies of MPH concentration measureme...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Drug Metab Pharmacokinet
Päätekijät: Chermá, Maria D., Josefsson, Martin, Rydberg, Irene, Woxler, Per, Trygg, Tomas, Hollertz, Olle, Gustafsson, Per A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2016
Aiheet:
Original Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5340830/
https://ncbi.nlm.nih.gov/pubmed/27220743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-016-0346-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia